Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models

Nanomedicine

Volumn 8, Issue 12, 2013, Pages 1913-1925

  Weng, Kevin C ^a   Hashizume, Rintaro ^b,c   Noble, Charles O ^d   Serwer, Laura P ^b,c   Drummond, Daryl C ^d   Kirpotin, Dmitri B ^d   Kuwabara, Anne M ^e   Chao, Lucy X ^e   Chen, Fanqing F ^f   James, Charles D ^b,c   Park, John W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Hermes Biosciences   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

brain tumor model; convection enhanced delivery; drug delivery system; immunoliposome; in vivo imaging; nanomedicine; quantum dot; targeted cancer therapy; targeted nanoparticle

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOLIPOSOME; NANOPARTICLE; QUANTUM DOT; QUANTUM DOT IMMUNOLIPOSOME HYBRID NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; BIOLUMINESCENCE; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CONVECTION ENHANCED DELIVERY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LIPOSOMAL DELIVERY; MOLECULAR IMAGING; MOLECULARLY TARGETED THERAPY; MOUSE; NANOFABRICATION; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; THERMODYNAMICS; TUMOR MODEL; TUMOR XENOGRAFT;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CONVECTION; DRUG DELIVERY SYSTEMS; FEMALE; GLIOBLASTOMA; HUMANS; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, NUDE; QUANTUM DOTS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84889560353     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.209     Document Type: Article

References (35)

1. Brem SS, Bierman PJ, Brem H et al. Central nervous system cancers. J. Natl Compr. Canc. Netw. 2011(9), 352-400 (2011
2. Pardridge WM. Drug targeting to the brain. Pharm. Res. 24(9), 1733-1744 (2007 (Pubitemid 47206623)
3. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH. Convection enhanced delivery of macromolecules in the brain. Proc. Natl Acad. Sci. USA 91(6), 2076-2080 (1994 (Pubitemid 24092045)
4. Krauze MT, Saito R, Noble C et al. Reflux free cannula for convection-enhanced high-speed delivery of therapeutic agents. J. Neurosurg. 103(5), 923-929 (2005 (Pubitemid 43194589)
5. Bidros DS, Liu JK, Vogelbaum MA. Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol. 6(1), 117-125 (2010
6. Kunwar S, Chang S, Westphal M et al. Phase III randomized trial of CED of IL13 PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol. 12(8), 871-881 (2010
7. Mamot C, Nguyen JB, Pourdehnad M et al. Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J. Neurooncol. 68(1), 1-9 (2004 (Pubitemid 39137344)
8. Saito R, Bringas JR, McKnight TR et al. Distribution of lposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res. 64(7), 2572-2579 (2004 (Pubitemid 38523915)
9. Krauze Mt, Forsayeth J, Park JW, Bankiewicz KS. Real-Time imaging and quantification of brain delivery of liposomes. Pharm. Res. 23(11), 2493-2504 (2006 (Pubitemid 44691597)
10. Noble CO, Krauze MT, Drummond DC et al. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: Pharmacology and efficacy. Cancer Res. 66(5), 2801-2806 (2006
11. Saito R, Krauze MT, Noble CO et al. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro. Oncol. 8(3), 205-214 (2006 (Pubitemid 46542645)
12. Krauze MT, Noble CO, Kawaguchi T et al. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and pegylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro. Oncol. 9(4), 393 (2007
13. Yamashita Y, Krauze MT, Kawaguchi T et al. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neuro. Oncol. 9(1), 20-28 (2007 (Pubitemid 46543485)
14. Mackay JA, Li W, Huang Z et al. HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convection-enhanced delivery. Mol. Ther. 16(5), 893-900 (2008 (Pubitemid 351587099)
15. Saito R, Krauze MT, Noble CO et al. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: Implications for local drug delivery. J. Neurosci. Methods 154(1-2), 225-232 (2004 (Pubitemid 43949058)
16. Murad GJA, Walbridge S, Morrison PF et al. Real-Time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin. Cancer Res. 12(10), 3145-3151 (2006 (Pubitemid 43837363)
17. Bidros DS, Vogelbaum MA. Novel drug delivery strategies in neuro-oncology. Neurotherapeutics 6(3), 539-546 (2009
18. Serwer L, Hashizume R, Ozawa T, James CD. Systemic and local drug delivery for treating diseases of the central nervous system in rodent models. J. Vis. Exp. 42, e1992 (2010
19. Noble CO, Kirpotin DB, Hayes ME et al. Development of ligand-Targeted liposomes for cancer therapy. Expert Opin. Ther. Targets 8(4), 335-353 (2004 (Pubitemid 39117698)
20. Mamot C, Drummond DC, Noble CO et al. Epidermal growth factor receptor-Targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res. 65(24), 11631-11638 (2005 (Pubitemid 41821723)
21. Kirpotin DB, Drummond DC, Shao Y et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 66(13), 6732-6740 (2006 (Pubitemid 44085631)
22. Pastorino F, Marimpietri D, Brignole C et al. Ligand-Targeted liposomal therapies of neuroblastoma. Curr. Med. Chem. 14(29), 3070-3078 (2007 (Pubitemid 350226958)
23. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4(6), 435-446 (2005 (Pubitemid 40774047)
24. Jaiswal JK, Goldman ER, Mattoussi H, Simon SM. Use of quantum dots for live cell imaging. Nat. Methods 1(1), 73-78 (2004
25. Alivisatos AP, Gu W, Larabell C. Quantum dots as cellular probes. Annu. Rev. Biomed. Eng. 7, 55-76 (2005 (Pubitemid 41170185)
26. Klostranec JM, Chan WCW. Quantum dots in biological and biomedical research: Recent progress and present challenges. Adv. Mater. 18(15), 1953-1964 (2006 (Pubitemid 44259247)
27. Ballou B, Ernst LA, Andreko S et al. Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug. Chem. 18(2), 389-396 (2007 (Pubitemid 46493509)
28. Weng KC, Noble CO, Papahadjopoulos-Sternberg B et al Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano Lett. 8(9), 2851-2857 (2008
29. Gao J, Chen X, Cheng Z. Near-infrared quantum dots as optical probes for tumor imaging. Curr. Top. Med. Chem. 10(12), 1147-1157 (2010
30. Sarkaria JN, Yang L, Grogan PT et al. Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel. Mol. Cancer Ther. 6(3), 1167-1174 (2007 (Pubitemid 46554588)
31. Hashizume R, Gupta N, Berger MS et al. Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing. Neuro. Oncol. 12(4), 336-376 (2010
32. Zhou Y, Drummond DC, Zou H et al. Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells. J. Mol. Biol. 371(4), 934-947 (2007 (Pubitemid 47103290)
33. Bentzen EL, Tomlinson ID, Mason J et al. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjug. Chem. 16(6), 1488-1494 (2005 (Pubitemid 41681516)
34. Sampson JH, Akabani G, Archer GE et al. Intracerebral infusion of an EGFR-Targeted toxin in recurrent malignant brain tumors. Neuro. Oncol. 10(3), 320-329 (2008
35. Park JW, Hong K, Kirpotin DB et al. Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery. Clin. Cancer Res. 8(4), 1172-1181 (2002 (Pubitemid 35177372)